CRISPR knockout screening in human A549 lung adenocarcinoma cells identified 5 EGF-resistance genes, and further RNAi validation showed DUSP1 increased survival of EGF treated cells, providing a novel target for EGFR-overexpressing cancers [86]. This evidence concerns the gene EGFR and cancer.